Table 2 Comparison of characteristics of the patients who survived and those who died
Survival | Death | ||
|---|---|---|---|
Number of patients | 187 | 61 | |
Age (years) | 65.7 ± 12.1 | 73.7 ± 9.8 | P < 0.01 |
Gender (m/f) | 102/85 | 35/26 | NS |
Body mass index (kg/m2) | 22.5 ± 3.6 | 20.9 ± 3.5 | P < 0.01 |
Dialysis history (months) | 64.9 ± 55.7 | 61.0 ± 57.2 | NS |
Diabetes (%) | 80 (43) | 41 (67) | P < 0.01 |
Hyperlipidemia drugs (%) | 22 (12) | 12 (20) | NS |
Systolic BP (mmHg) | 152 ± 20 | 150 ± 26 | NS |
Diastolic BP (mmHg) | 77 ± 14 | 73 ± 14 | NS |
Laboratory study | |||
Hemoglobin (g/dl) | 10.8 ± 0.9 | 10.9 ± 1.0 | NS |
High-density lipoprotein cholesterol (mg/dl) | 47.9 ± 15.3 | 43.9 ± 12.7 | NS |
Low-density lipoprotein cholesterol (mg/dl) | 87.5 ± 29.2 | 91.6 ± 30.2 | NS |
Triglyceride (mg/dl) | 100 ± 58 | 114 ± 87 | NS |
Uric acid (mg/dl) | 7.2 ± 1.4 | 7.0 ± 1.3 | NS |
Creatinine (mg/dl) | 9.9 ± 2.6 | 8.6 ± 2.1 | P < 0.01 |
C-reactive protein (mg/dl) | 0.3 ± 0.7 | 0.5 ± 0.8 | NS |
Ca (mg/dl) | 8.9 ± 0.5 | 8.9 ± 0.5 | NS |
Inorganic phosphorus (mg/dl) | 5.2 ± 1.1 | 5.1 ± 1.0 | NS |
Intact-parathyroid hormone (pg/ml) | 139 ± 80 | 151 ± 96 | NS |
Albumin (g/dl) | 3.7 ± 0.3 | 3.5 ± 0.4 | P < 0.01 |
Hemoglobin A1c (%) | 5.3 ± 0.8 | 5.5 ± 1.0 | NS |
Human atrial natriuretic polypeptide (pg/ml) | 60 ± 55 | 103 ± 197 | P < 0.01 |
Brain natriuretic peptide (pg/ml) | 216 ± 241 | 429 ± 693 | P < 0.01 |
Cardiothoracic ratio (%) | 51.7 ± 4.7 | 54.8 ± 6.3 | P < 0.01 |
Brachial-ankle pulse wave velocity (cm/s) | 1971 ± 540 | 2317 ± 894 | P < 0.01 |
Abdominal circumference (cm) | 84.4 ± 10.3 | 80.6 ± 10.1 | P < 0.05 |
Visceral fat area (cm2) | 89.8 ± 62.1 | 69.2 ± 49.7 | P < 0.05 |
Subcutaneous fat area (cm2) | 124.8 ± 71.3 | 97.6 ± 76.3 | P < 0.05 |